ScreenCell

🚨 Exciting Breakthrough Alert! 🚨 🔬 We are thrilled to announce that ScreenCell technology for analyzing circulating tumor cells (#CTCs) is now a part of the #clinicalroutine at Kahia Laboratory in Oran, Algeria! 🇩🇿💉 🌟 Why is this a game-changer? 🌟 Patients diagnosed with advanced breast cancer can now benefit from a cutting-edge, non-invasive #liquidbiopsy solution. This advancement allows for real-time monitoring of cancer progression and enables personalized treatment adjustments, elevating the standard of care. 🎗️ In this month of October, dedicated to breast cancer awareness, ScreenCell reaffirms its dedication to innovation and enhancing the quality of life for #breastcancer patients. Our ongoing clinical projects in collaboration with Laboratoire Kahia are a testament to our commitment to fighting this disease not just in #Algeria but worldwide. Join us in celebrating this milestone that marks a significant step forward in personalized medicine and cancer care. Together, we are pushing the boundaries of what's possible in healthcare! #ScreenCell #CancerResearch #PersonalizedMedicine #BreastCancerAwareness #Innovation #HealthcareTransformation

ScreenCell will be at the Liquid Biopsies Conference from November 12 to 14 2024 at École normale supérieure de Lyon organized by the European Association for Cancer Research (EACR). Join us at booth 4 for a unique opportunity to see live demonstrations of ScreenCell technology and our products. We'll also discuss the clinical benefits of #liquidbiopsy and #circulatingtumorcells. 🔗 For more information: https://lnkd.in/eUegpGen #EACR

🎗 #BreastCancerAwarenessMonth : Together, Let's Fight Against Breast Cancer 🎗 #Breastcancer is the most common malignant tumor in women and the deadliest in the world. In #France, over 60,000 new cases were diagnosed in 2023, and more than 900,000 women are currently affected by the disease. Despite these alarming figures, many women remain unaware of the risks. - 1 in 2 women are unaware of the dangers of breast cancer (53%). - 2 out of 3 women don’t know that alcohol is a major risk factor (63%). - 1 in 2 women don’t recognize tobacco as an aggravating factor (49%). Source : Ligue contre le cancer As a key player in the fight against breast cancer, ScreenCell is once again mobilizing to raise awareness about the importance of screening and prevention. 📢 Let’s share and spread this essential information! #liquidbiopsy #CTCs #oncology

We're #hiring a new Administrative and HR agent in Paris, Île-de-France. Apply today or share this post with your network. Nous #recrutons actuellement un(e) Responsable administratif et RH à Paris, Île-de-France. Postulez dès aujourd'hui ou partagez cette publication avec votre réseau.

🔬 ScreenCell présente aux Assises des Biothérapies et de la Bioproduction de la Région Bourgogne-Franche-Comté🧬 Nous avons eu l'opportunité d'assister hier aux assises dédiées à la biothérapie, où la feuille de route 2024-2028 de ce projet ambitieux a été dévoilée. Nous sommes enthousiastes à l'idée de suivre les avancées de cette initiative et espérons que ScreenCell jouera un rôle clé dans cette aventure passionnante ! #ScreenCell #Santé #Biothérapie #Innovation

🎉 𝗧𝗵𝗮𝗻𝗸𝘀 𝘁𝗼 𝗼𝘂𝗿 𝟭,𝟬𝟬𝟬 𝘀𝘂𝗯𝘀𝗰𝗿𝗶𝗯𝗲𝗿𝘀! 🎉 We're thrilled to see our community growing every day. Thank you all for your interest in our technology, our products and #CTCs. 𝗡𝗲𝘄 𝘀𝘂𝗯𝘀𝗰𝗿𝗶𝗯𝗲𝗿𝘀, 𝗳𝗲𝗲𝗹 𝗳𝗿𝗲𝗲 𝘁𝗼 𝘀𝗲𝗻𝗱 𝘂𝘀 𝗮 𝗽𝗿𝗶𝘃𝗮𝘁𝗲 𝗺𝗲𝘀𝘀𝗮𝗴𝗲 𝗼𝗻 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻 𝘄𝗶𝘁𝗵 𝗮𝗻𝘆 𝗾𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀! #liquidbiopsy #cancercell

🔬 Back to work at ScreenCell! 🔬 We are thrilled to have our teams back in the lab, ready to innovate and move forward together. Don’t forget to check your supplies and ensure your kits are complete for an efficient and organized return! #liquidbiopsy #cancercell #circulatingtumorcells

🤝 ScreenCell is proud to join the European Liquid Biopsy Society (ELBS) and reaffirm its commitment to #liquidbiopsy advancement!  🏢 With over 87 institutes across three continents, the ELBS integrates key players from academia, the clinics, industry and national government agencies to collectively advance the field of liquid biopsy. We are honored to contribute to this important mission and to collaborate with these like-minded players. ✉ You can now contact our representatives at ELBS by clicking on the following link: https://lnkd.in/esyKfN3K

🤝 ScreenCell is proud to join the European Liquid Biopsy Society (ELBS) and reaffirm its commitment to #liquidbiopsy advancement!  🏢 With over 87 institutes across three continents, the ELBS integrates key players from academia, the clinics, industry and national government agencies to collectively advance the field of liquid biopsy. We are honored to contribute to this important mission and to collaborate with these like-minded players. ✉ You can now contact our representatives at ELBS by clicking on the following link: https://lnkd.in/esyKfN3K

🤝 ScreenCell is proud to join the European Liquid Biopsy Society (ELBS) and reaffirm its commitment to #liquidbiopsy advancement!  🏢 With over 87 institutes across three continents, the ELBS integrates key players from academia, the clinics, industry and national government agencies to collectively advance the field of liquid biopsy. We are honored to contribute to this important mission and to collaborate with these like-minded players. ✉ You can now contact our representatives at ELBS by clicking on the following link: https://lnkd.in/esyKfN3K